home > ebr

European Biopharmaceutical Review


European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:


Simon Caplan

George Briggs


Vanessa Kintu



Connect with us on Twitter: follow @EBRmagazine


 Click here to view the digital version of EBR   

Featured in this issue
Eschewing the Escalation of Salaries as Safety Professionals Grow Scarcer

Alan White at Arriello

Qualified PV professionals are proving particularly hard to hang on to as demand for experienced safety talent soars. As such, it seems like a good time to look beyond financial remuneration as the key to keeping valued staff motivated and loyal.
Transforming Cell and Gene Therapy Trial Design and Execution

Martin Lachs at ICON plc

With over 400 dedicated CGT professionals globally, ICON has developed tools and best practices to transform CGT trial design and execution
Unlocking the Potential of Checkpoint Inhibitors The Challenge for the Next Decade

Marisol Quintero at Highlight Therapeutics

Immunotherapy is an exciting weapon against cancer but many patients fail to benefit. Scientists are increasingly focused on maximising the potential of the immune system for everyone, perhaps in combination with one of the oldest cancer treatments: radiotherapy.


Published quarterly in
January, April,
July, and October


Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Backward Thinking

Development of a generic equivalent to a current marketed pressurized metered dose inhaler (pMDI) product brings immense challenges. Thorough analysis is critical to gain a comprehensive understanding of the physical attributes and pharmaceutical performance of the reference marketed product. Many factors need to be assessed, understood and combined in order to successfully develop a generic pMDI which will meet the regulatory and quality requirements as an equivalent product in the anticipated target market.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement